» Articles » PMID: 24052469

Alterations in Tubular Epithelial Cells in Diabetic Nephropathy

Overview
Journal J Nephrol
Publisher Springer
Specialty Nephrology
Date 2013 Sep 21
PMID 24052469
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Renal hypertrophy, matrix protein accumulation and tubulointerstitial fibrosis are major pathological features of diabetic nephropathy (DN) that eventuate in renal failure. Hyperglycemia and high concentration of glucose increase matrix protein expression, but the pathogenic mechanisms are not fully understood. We have previously reported that inactivation of tuberin resulting in activation of the mammalian target of rapamycin (mTOR) pathway and increased matrix protein accumulation in cultured proximal tubular cells exposed to high glucose and in kidney cortex of rats with type 1 diabetes. In this report, we show that kidney sections of diabetic patients express higher levels of phospho-tuberin (inactive form of tuberin), and that is associated with an increase in mTOR activation as measured by phosphorylation level of p70S6K. Inactivation of tuberin and activation of mTOR lead to accumulated cell matrix proteins (fibronectin and collagen IV) mainly in tubular epithelial cells of the kidneys of diabetic patients. In addition, significant staining of vimentin as a marker of cells undergoing an epithelial-to-mesenchymal transition (EMT) was detected in kidney sections of diabetic patients. On the other hand, very weak or nondetectable staining of cell matrix proteins, p-tuberin and P-p70S6K as well as vimentin was found in normal kidney sections of healthy subjects. The morphological changes in kidney sections of diabetic patients showed tubular thickening, glomerular and tubular hypertrophy, compared to normal structure of tubuli and glomeruli in kidney from healthy control subjects. These data suggest that alterations in tubular cells' structure, including tubular thickening and hypertrophy, are major mediators of the fibrotic process in DN.

Citing Articles

Identifying the mechanisms and molecular targets of Hongjingtian injection on treatment of TGFβ1-induced HK-2 cells: coupling network pharmacology with experimental verification.

Sun G, Jiao M, Cui Y, Liang X, Liang X, Zhang S Ann Transl Med. 2023; 10(24):1329.

PMID: 36660701 PMC: 9843345. DOI: 10.21037/atm-22-5035.


Expression of growth arrest specific 1 (Gas1) in the distal tubules and collecting ducts in normal kidney and in the early stages of diabetic nephropathy.

Luna-Antonio B, Rodriguez-Munoz R, Namorado-Tonix C, Perez-Lopez A, Sanchez E, Vergara P J Mol Histol. 2022; 53(6):925-946.

PMID: 36272046 DOI: 10.1007/s10735-022-10104-7.


Changes in Serum Intact Fibroblast Growth Factor 23 Concentrations From Midlife to Late Life and Their Predictors in the Community: The ARIC Study.

Ishigami J, Honda Y, Karger A, Coresh J, Selvin E, Lutsey P Mayo Clin Proc Innov Qual Outcomes. 2022; 6(3):209-217.

PMID: 35517245 PMC: 9062741. DOI: 10.1016/j.mayocpiqo.2022.03.002.


A novel role of snail in regulating tuberin/AMPK pathways to promote renal fibrosis in the new mouse model of type II diabetes.

Liang S, Yadav M, Vogel K, Habib S FASEB Bioadv. 2021; 3(9):730-743.

PMID: 34485841 PMC: 8409551. DOI: 10.1096/fba.2020-00134.


Wogonin Alleviates Kidney Tubular Epithelial Injury in Diabetic Nephropathy by Inhibiting PI3K/Akt/NF-κB Signaling Pathways.

Lei L, Zhao J, Liu X, Chen J, Qi X, Xia L Drug Des Devel Ther. 2021; 15:3131-3150.

PMID: 34295152 PMC: 8291679. DOI: 10.2147/DDDT.S310882.